LncRNA LINC01278 Regulates the Prognosis and Related Mechanisms of Gastric Cancer by Targeting miR-129-5p-Reference-Cited by-同舟云学术

LncRNA LINC01278 Regulates the Prognosis and Related Mechanisms of Gastric Cancer by Targeting miR-129-5p

Published:2024 Issue:4 Volume:43 Page:43-52
ISSN:0731-8898
Container-title:Journal of Environmental Pathology, Toxicology and Oncology
language:en
Short-container-title:J Environ Pathol Toxicol Oncol

Author:

Wang Zhenhua,Liu Liyan,Li Zhengliang,Liu Xiaojing,Wang Jundong,Wang Jiaxi,Jiang Guoxiang,Yu Haizhou

Abstract

Gastric cancer, a prevalent malady within the digestive tract, has a complex pathological mechanism and numerous patients. The regulation of gastric cancer process by long non-coding RNA (lncRNA) presented new prospects for the study of its molecular mechanism and the treatment of patients. The abnormal expressed genes in gastric cancer were screened by GSE193109 dataset. The correlation between LINC01278 and the likelihood of survival in patients suffering from gastric cancer was investigated by Kaplan-Meier survival curve and multivariate Cox analysis. LINC01278 in gastric cancer tissue samples and cells was verified via RT-qPCR. The cell counting kit-8 (CCK-8) and transwell assay were selected to detect the growth activity of gastric cancer cells. The association between LINC01278 and miR-129-5p was validated through luciferase reporter assay and RNA-binding protein immunoprecipitation (RIP) assay. Correlation analysis of clinical features revealed an association between LINC01278 and the prognosis in gastric cancer patients. LINC01278 was actively expressed in gastric cancer, which exerts a tumor-promoting effect. Silencing LINC01278 suppressed the biological function of tumor cells through spongiform miR-129-5p. LINC01278 has the potential to serve as a novel biomarker, offering new avenues of research for the prognosis and treatment of gastric cancer.

Publisher

Begell House

Link

https://www.dl.begellhouse.com/download/article/216d73850ff1984b/JEP(T)-53208.pdf

Reference31 articles.

1. Li G, Ding K, Qiao Y, Zhang L, Zheng L, Pan T, Zhang L. Flavonoids regulate inflammation and oxidative stress in cancer. Molecules. 2020;25(23).

2. Tian YQ, Hu D, Zhang YL, Zou J, Chen GL, Guo MQ. Inhibitors targeting multiple Janus kinases from Zanthoxylum simulans mediate inhibition and apoptosis against gastric cancer cells via the estrogen pathway. Front Chem. 2022;10:922110.

3. Liu Y, Hao Y, Zhao H, Zhang Y, Cheng D, Zhao L, Peng Y, Lu Y, Li Y. PlexinA1 activation induced by B2-AR promotes epithelial-mesenchymal transition through JAKSTAT3 signaling in human gastric cancer cells. J Cancer. 2022;13(7):2258â70.

4. Zhang Z, Han S, Ouyang S, Zeng Z, Liu Z, Sun J, Kang W. PDK4 constitutes a novel prognostic biomarker and therapeutic target in gastric cancer. Diagnostics. 2022;12(5).

5. Ma J, Zhang C, Liang W, Li L, Du J, Pan C, Chen B, Chen Y, Wang Y. w-3 and w-6 polyunsaturated fatty acids regulate the proliferation, invasion and angiogenesis of gastric cancer through COX/PGE signaling pathway. Front Oncol. 2022;12:802009.